labetalol has been researched along with Adrenal Cancer in 49 studies
Labetalol: A salicylamide derivative that is a non-cardioselective blocker of BETA-ADRENERGIC RECEPTORS and ALPHA-1 ADRENERGIC RECEPTORS.
labetalol : A diastereoisomeric mixture of approximately equal amounts of all four possible stereoisomers ((R,S)-labetolol, (S,R)-labetolol, (S,S)-labetalol and (R,R)-labetalol). It is an adrenergic antagonist used to treat high blood pressure.
2-hydroxy-5-{1-hydroxy-2-[(4-phenylbutan-2-yl)amino]ethyl}benzamide : A member of the class of benzamides that is benzamide substituted by a hydroxy group at position 2 and by a 1-hydroxy-2-[(4-phenylbutan-2-yl)amino]ethyl group at position 5.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To report a case of pheochromocytoma exhibiting an increase in systemic vascular resistance index (SVRI) and decreased cardiac index (CI) after use of labetalol." | 7.71 | Elevated vascular resistance after labetalol during resection of a pheochromocytoma (brief report). ( Chung, PC; Li, AH; Lin, CC; Yang, MW, 2002) |
| "A case of intrahepatic metastatic pheochromocytoma with lymph nodes involvement undergoing resection of tumor was reported; intravenous labetalol in high dose regimen (2 mg/kg administered before skin incision) was used for blood pressure control during the operation." | 7.69 | High dose intravenous labetalol for the resection of metastatic pheochromocytoma. ( Chung, PC; Sum, DC; Wu, RS, 1996) |
| "A patient with pheochromocytoma was studied by MIBG scintigraphy while on labetalol therapy, which has been reported to interfere with imaging." | 7.68 | MIBG scintigraphy of a patient with pheochromocytoma on labetalol therapy. ( Bardies, M; Chatal, JF; Chetanneau, A; Kremer, M; Le Marec, H; Morais, J; Peltier, P, 1992) |
| "Labetalol, an alpha and beta adrenergic blocking drug, was used during anesthesia for removal of a very large pheochromocytoma which was predominantly epinephrine secreting." | 7.66 | Use of labetalol during anesthesia for pheochromocytoma removal. ( de Rood, M; Lambilliotte, JP; Levarlet, M; Lignian, H; Van Stratum, M, 1983) |
| "1 We have compared, in patients with severe hypertension, the administration of intravenous labetalol by single rapid injection, by repeated bolus injections, and by incremental infusion." | 7.66 | Intravenous labetalol in the treatment of severe hypertension. ( Brown, JJ; Cumming, AM; Lever, AF; Robertson, JI, 1982) |
| "Labetalol is an orally active adrenoceptor blocking drug which is a competitive antagonist at both alpha- and beta-adrenoceptor sites." | 6.36 | Labetalol: a review of its pharmacology and therapeutic use in hypertension. ( Avery, GS; Brogden, RN; Heel, RC; Speight, TM, 1978) |
| "Pheochromocytoma is a catecholamine-producing tumor but rarely delayingly diagnosed until during pregnancy." | 5.37 | Cardiovascular collapse after labetalol for hypertensive crisis in an undiagnosed pheochromocytoma during cesarean section. ( Huang, CS; Ko, YP; Kuok, CH; Tsai, PS; Yen, CR, 2011) |
| "Labetalol was used as antihypertensive agent and was given in repeated bolus (up to total dose of 2 mg/kg) intravenously before skin incision and no supplemental dosage was given later on." | 5.29 | Preliminary experience of using fixed dose of intravenous labetalol in surgical resection of pheochromocytoma. ( Chung, PC; Sum, DC, 1993) |
| "Labetalol is an antihypertensive agent with combined alpha- and beta-blocking properties that has been used to manage patients with suspected pheochromocytomas." | 5.28 | Labetalol reduces iodine-131 MIBG uptake by pheochromocytoma and normal tissues. ( Fig, LM; Khafagi, FA; Mallette, S; Shapiro, B; Sisson, JC, 1989) |
| "To report a case of pheochromocytoma exhibiting an increase in systemic vascular resistance index (SVRI) and decreased cardiac index (CI) after use of labetalol." | 3.71 | Elevated vascular resistance after labetalol during resection of a pheochromocytoma (brief report). ( Chung, PC; Li, AH; Lin, CC; Yang, MW, 2002) |
| "A 22-year-old woman diagnosed with pheochromocytoma was medically managed at 33 weeks gestation with oral phenoxybenzamine and labetalol until delivery 26 days later." | 3.69 | Phenoxybenzamine placental transfer during the third trimester. ( Santeiro, ML; Stromquist, C; Wyble, L, 1996) |
| "A case of intrahepatic metastatic pheochromocytoma with lymph nodes involvement undergoing resection of tumor was reported; intravenous labetalol in high dose regimen (2 mg/kg administered before skin incision) was used for blood pressure control during the operation." | 3.69 | High dose intravenous labetalol for the resection of metastatic pheochromocytoma. ( Chung, PC; Sum, DC; Wu, RS, 1996) |
| "A patient with pheochromocytoma was studied by MIBG scintigraphy while on labetalol therapy, which has been reported to interfere with imaging." | 3.68 | MIBG scintigraphy of a patient with pheochromocytoma on labetalol therapy. ( Bardies, M; Chatal, JF; Chetanneau, A; Kremer, M; Le Marec, H; Morais, J; Peltier, P, 1992) |
| "Labetalol, an alpha and beta adrenergic blocking drug, was used during anesthesia for removal of a very large pheochromocytoma which was predominantly epinephrine secreting." | 3.66 | Use of labetalol during anesthesia for pheochromocytoma removal. ( de Rood, M; Lambilliotte, JP; Levarlet, M; Lignian, H; Van Stratum, M, 1983) |
| "1 We have compared, in patients with severe hypertension, the administration of intravenous labetalol by single rapid injection, by repeated bolus injections, and by incremental infusion." | 3.66 | Intravenous labetalol in the treatment of severe hypertension. ( Brown, JJ; Cumming, AM; Lever, AF; Robertson, JI, 1982) |
| "A preoperative patient with pheochromocytoma was satisfactorily treated with oral labetalol, while a conspicuous increase in urinary output of catecholamines (CA) and of vanillylmandelic acid (VMA) was observed after labetalol therapy." | 3.66 | Falsely high urinary catecholamines induced by labetalol. ( Abe, K; Adachi, M; Kobayashi, K; Miura, Y; Sakuma, H; Tomioka, H; Yoshinaga, K, 1979) |
| "The dosage of urinary catecholamines and their metabolites is a main element of diagnosis in the research of a pheochromocytoma in patients with high blood pressure." | 2.67 | [Absence of labetalol interference on urine metanephrine determination in hypertensive patients]. ( Billaud, EM; Girerd, X; Laurent, S; Ropers, J; Safar, M; Safavian, A; Sorrel-Dejerine, A, 1992) |
| "Labetalol is a unique antihypertensive agent which is a competitive peripheral antagonist at both alpha- and beta-adrenoceptor sites." | 2.37 | Current status of labetalol, the first alpha- and beta-blocking agent. ( Kanto, JH, 1985) |
| "Labetalol is an orally active adrenoceptor blocking drug which is a competitive antagonist at both alpha- and beta-adrenoceptor sites." | 2.36 | Labetalol: a review of its pharmacology and therapeutic use in hypertension. ( Avery, GS; Brogden, RN; Heel, RC; Speight, TM, 1978) |
| "Giant pheochromocytomas are rare tumors, with the majority being clinically silent." | 1.91 | A Giant Pheochromocytoma Presenting in Pheochromocytoma Crisis: A Case Report. ( Baniya, S; Bogati, K; Karki, N; Pokhrel, M; Regmi, UK; Thapa, S, 2023) |
| "Pheochromocytoma is a catecholamine-producing tumor but rarely delayingly diagnosed until during pregnancy." | 1.37 | Cardiovascular collapse after labetalol for hypertensive crisis in an undiagnosed pheochromocytoma during cesarean section. ( Huang, CS; Ko, YP; Kuok, CH; Tsai, PS; Yen, CR, 2011) |
| "Labetalol was used as antihypertensive agent and was given in repeated bolus (up to total dose of 2 mg/kg) intravenously before skin incision and no supplemental dosage was given later on." | 1.29 | Preliminary experience of using fixed dose of intravenous labetalol in surgical resection of pheochromocytoma. ( Chung, PC; Sum, DC, 1993) |
| "Labetalol is an antihypertensive agent with combined alpha- and beta-blocking properties that has been used to manage patients with suspected pheochromocytomas." | 1.28 | Labetalol reduces iodine-131 MIBG uptake by pheochromocytoma and normal tissues. ( Fig, LM; Khafagi, FA; Mallette, S; Shapiro, B; Sisson, JC, 1989) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 30 (61.22) | 18.7374 |
| 1990's | 11 (22.45) | 18.2507 |
| 2000's | 6 (12.24) | 29.6817 |
| 2010's | 1 (2.04) | 24.3611 |
| 2020's | 1 (2.04) | 2.80 |
| Authors | Studies |
|---|---|
| Bogati, K | 1 |
| Baniya, S | 1 |
| Thapa, S | 1 |
| Regmi, UK | 1 |
| Karki, N | 1 |
| Pokhrel, M | 1 |
| Asencio Moreno, A | 1 |
| Alamán Orbañanos, B | 1 |
| Moro Velasco, MC | 1 |
| Kuok, CH | 1 |
| Yen, CR | 1 |
| Huang, CS | 1 |
| Ko, YP | 1 |
| Tsai, PS | 1 |
| Kai, H | 1 |
| Imaizumi, T | 1 |
| Lewis, S | 1 |
| Dirnhuber, M | 1 |
| Soar, J | 1 |
| Hiéronimus, S | 1 |
| Bernard, JL | 1 |
| Chevallier, P | 1 |
| Chevallier, A | 1 |
| Chyderiotis, G | 1 |
| Fenichel, P | 1 |
| Landraud, L | 1 |
| Noppers, IM | 1 |
| Zijlstra, JG | 1 |
| Russell, WJ | 2 |
| Kaines, AH | 1 |
| Hooper, MJ | 1 |
| Frewin, DB | 2 |
| van Hasselt, G | 1 |
| MacKenzie, I | 1 |
| Edwards, JC | 1 |
| Reid, JL | 1 |
| Meredith, PA | 1 |
| Elliott, HL | 1 |
| Yoshinaga, K | 3 |
| Arakawa, K | 2 |
| Ando, H | 1 |
| Iai, F | 1 |
| Ikeda, M | 3 |
| Sugano, O | 1 |
| Hirano, J | 1 |
| Hirano, K | 1 |
| Kubota, Y | 1 |
| Numasawa, K | 1 |
| Kawamura, S | 1 |
| Navaratnarajah, M | 1 |
| White, DC | 1 |
| Galletly, DC | 1 |
| Yee, P | 1 |
| Maling, TJ | 1 |
| Van Stratum, M | 1 |
| Levarlet, M | 1 |
| Lambilliotte, JP | 1 |
| Lignian, H | 1 |
| de Rood, M | 1 |
| Stewart, PA | 1 |
| Robertson, JI | 2 |
| Cumming, AM | 1 |
| Brown, JJ | 1 |
| Lever, AF | 1 |
| Ebihara, T | 1 |
| Oe, N | 1 |
| Reach, G | 1 |
| Thibonnier, M | 1 |
| Chevillard, C | 1 |
| Corvol, P | 1 |
| Milliez, P | 1 |
| Feek, CM | 1 |
| Earnshaw, PM | 1 |
| Sheaves, R | 1 |
| Chew, SL | 1 |
| Grossman, AB | 1 |
| Apeldoorn, L | 1 |
| Voerman, HJ | 1 |
| Hoefnagel, CA | 1 |
| Chung, PC | 3 |
| Sum, DC | 2 |
| Santeiro, ML | 1 |
| Stromquist, C | 1 |
| Wyble, L | 1 |
| Wu, RS | 1 |
| Metcalfe, IR | 1 |
| Tonkin, AL | 1 |
| Armero, R | 1 |
| Vicente, R | 1 |
| Alepuz, R | 1 |
| Li, AH | 1 |
| Lin, CC | 1 |
| Yang, MW | 1 |
| Brogden, RN | 1 |
| Heel, RC | 1 |
| Speight, TM | 1 |
| Avery, GS | 1 |
| Briggs, RS | 1 |
| Birtwell, AJ | 1 |
| Pohl, JE | 1 |
| FitzGerald, GA | 1 |
| Lax, P | 1 |
| Ruthven, CR | 1 |
| Sandler, M | 1 |
| Nyberg, G | 1 |
| Waldenström, J | 1 |
| Vedin, A | 1 |
| Bailey, RR | 1 |
| Kaufman, L | 1 |
| Kobayashi, K | 1 |
| Miura, Y | 1 |
| Tomioka, H | 1 |
| Sakuma, H | 1 |
| Adachi, M | 1 |
| Abe, K | 1 |
| Girerd, X | 1 |
| Billaud, EM | 1 |
| Sorrel-Dejerine, A | 1 |
| Ropers, J | 1 |
| Safavian, A | 1 |
| Safar, M | 1 |
| Laurent, S | 1 |
| Morais, J | 1 |
| Le Marec, H | 1 |
| Peltier, P | 1 |
| Chetanneau, A | 1 |
| Kremer, M | 1 |
| Bardies, M | 1 |
| Chatal, JF | 1 |
| Sheps, SG | 1 |
| Jiang, NS | 1 |
| Klee, GG | 1 |
| van Heerden, JA | 1 |
| Crawford, GA | 1 |
| Györy, AZ | 1 |
| Gallery, ED | 1 |
| Kelly, D | 1 |
| Khafagi, FA | 1 |
| Shapiro, B | 1 |
| Fig, LM | 1 |
| Mallette, S | 1 |
| Sisson, JC | 1 |
| Pelegrí, A | 1 |
| Romero, R | 1 |
| Reguant, M | 1 |
| Aisa, L | 1 |
| Kanto, JH | 1 |
| Blom, HJ | 1 |
| Karsdorp, V | 1 |
| Birnie, R | 1 |
| Davies, G | 1 |
| Debache, N | 1 |
| Bleinc, D | 1 |
| Touboul, A | 1 |
| Haquin, G | 1 |
| Chouty, F | 1 |
| Lardoux, H | 1 |
| Sheikh, A | 1 |
| Kojima, S | 1 |
| Natsume, T | 1 |
| Ito, K | 1 |
| Bouloux, PM | 1 |
| Featherstone, RM | 1 |
| Clement-Jones, V | 1 |
| Rees, LH | 1 |
| Goligher, JE | 1 |
5 reviews available for labetalol and Adrenal Cancer
| Article | Year |
|---|---|
[Protective effect of alpha beta-blockers on hypertensive target-organ damage].
Topics: Adrenal Gland Neoplasms; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Antihypertensive | 2004 |
Labetalol and the management of hypertension.
Topics: Adrenal Gland Neoplasms; Clonidine; Ethanolamines; Humans; Hypertension; Labetalol; Pheochromocytoma | 1981 |
Labetalol: a review of its pharmacology and therapeutic use in hypertension.
Topics: Adrenal Gland Neoplasms; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Angiotensin II; | 1978 |
Recent developments in the diagnosis and treatment of pheochromocytoma.
Topics: Adrenal Gland Neoplasms; alpha-Methyltyrosine; Humans; Labetalol; Methyltyrosines; Pheochromocytoma; | 1990 |
Current status of labetalol, the first alpha- and beta-blocking agent.
Topics: Adrenal Gland Neoplasms; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Anesthesia; Biot | 1985 |
2 trials available for labetalol and Adrenal Cancer
| Article | Year |
|---|---|
[Clinical effects of labetalol on pheochromocytoma].
Topics: Adolescent; Adrenal Gland Neoplasms; Adult; Aged; Clinical Trials as Topic; Ethanolamines; Female; H | 1983 |
[Absence of labetalol interference on urine metanephrine determination in hypertensive patients].
Topics: Adrenal Gland Neoplasms; Adult; Aged; Chromatography, Liquid; Female; Humans; Hypertension; Labetalo | 1992 |
42 other studies available for labetalol and Adrenal Cancer
| Article | Year |
|---|---|
A Giant Pheochromocytoma Presenting in Pheochromocytoma Crisis: A Case Report.
Topics: Adrenal Gland Neoplasms; Antihypertensive Agents; Female; Humans; Hypertension; Labetalol; Middle Ag | 2023 |
[Anesthesia for the surgical removal of bilateral pheochromocytomas during the second trimester of pregnancy].
Topics: Adrenal Gland Neoplasms; Adrenergic alpha-Antagonists; Adult; Anesthesia, Epidural; Anesthesia, Gene | 2009 |
Cardiovascular collapse after labetalol for hypertensive crisis in an undiagnosed pheochromocytoma during cesarean section.
Topics: Adrenal Gland Neoplasms; Adrenergic beta-Antagonists; Adult; Cesarean Section; Female; Humans; Hyper | 2011 |
An unusual presentation of a pheochromocytoma.
Topics: Adrenal Gland Neoplasms; Humans; Hypertension; Labetalol; Male; Middle Aged; Pheochromocytoma | 2006 |
Adrenal tuberculosis after a pheochromocytoma: a misleading tumoral presentation.
Topics: Adrenal Gland Diseases; Adrenal Gland Neoplasms; Adrenergic alpha-Antagonists; Anti-Inflammatory Age | 2007 |
Undulating blood pressure.
Topics: Adrenal Gland Neoplasms; Adrenal Glands; Adrenalectomy; Antihypertensive Agents; Blood Pressure; Fem | 2008 |
Labetalol in the preoperative management of phaeochromocytoma.
Topics: Adrenal Gland Neoplasms; Adrenergic alpha-Antagonists; Blood Pressure; Dopamine; Epinephrine; Ethano | 1982 |
Use of vecuronium and labetalol in patients with phaeochromocytoma.
Topics: Adrenal Gland Neoplasms; Adult; Anesthesia; Humans; Hypertension; Jaw Fractures; Labetalol; Male; Pa | 1984 |
[Malignant pheochromocytoma: blood pressure controlled by labetalol].
Topics: Adrenal Gland Neoplasms; Adult; Ethanolamines; Humans; Hypertension; Labetalol; Male; Pheochromocyto | 1984 |
Labetalol and phaeochromocytoma.
Topics: Adrenal Gland Neoplasms; Ethanolamines; Female; Humans; Hypertension; Labetalol; Pheochromocytoma | 1984 |
Anaesthetic management of combined caesarean section and phaeochromocytoma removal.
Topics: Adrenal Gland Neoplasms; Adult; Anesthesia, General; Atenolol; Cesarean Section; Female; Humans; Lab | 1983 |
Use of labetalol during anesthesia for pheochromocytoma removal.
Topics: Adrenal Gland Neoplasms; Aged; Anesthesia; Epinephrine; Ethanolamines; Female; Humans; Hypertension; | 1983 |
Adrenal phaeochromocytoma in familial neurofibromatosis with initial control of hypertension by labetalol.
Topics: Adrenal Gland Neoplasms; Female; Humans; Hypertension; Labetalol; Middle Aged; Neurofibromatosis 1; | 1982 |
Labetalol: the nineteen-eighties.
Topics: Adrenal Gland Neoplasms; Anesthesia; Coronary Disease; Ethanolamines; Female; Humans; Hypertension; | 1982 |
Intravenous labetalol in the treatment of severe hypertension.
Topics: Adrenal Gland Neoplasms; Catecholamines; Clonidine; Ethanolamines; Humans; Hypertension; Infusions, | 1982 |
[Clinical effects of labetalol in 21 patients with phaeochromocytoma (author's transl)].
Topics: Adolescent; Adrenal Gland Neoplasms; Adult; Aged; Ethanolamines; Female; Humans; Labetalol; Male; Mi | 1981 |
Effect of labetalol on blood pressure and plasma catecholamine concentrations in patients with phaeochromocytoma.
Topics: Adrenal Gland Neoplasms; Blood Pressure; Epinephrine; Ethanolamines; Heart Rate; Humans; Labetalol; | 1980 |
Hypertensive response to labetalol in phaeochromocytoma.
Topics: Adrenal Gland Neoplasms; Blood Pressure; Ethanolamines; Humans; Labetalol; Male; Middle Aged; Pheoch | 1980 |
The dangers of unopposed beta-adrenergic blockade in phaeochromocytoma.
Topics: Adrenal Gland Neoplasms; Adrenergic alpha-Antagonists; Adult; Aged; Fatal Outcome; Female; Humans; L | 1995 |
Interference of MIBG uptake by medication: a case report.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Contrast Media; Diagnosis, Differential; Drug Intera | 1995 |
Preliminary experience of using fixed dose of intravenous labetalol in surgical resection of pheochromocytoma.
Topics: Adrenal Gland Neoplasms; Adult; Aged; Anesthesia; Blood Pressure; Heart Rate; Humans; Injections, In | 1993 |
Phenoxybenzamine placental transfer during the third trimester.
Topics: Adrenal Gland Neoplasms; Adult; Antihypertensive Agents; Female; Fetal Blood; Humans; Hypertension; | 1996 |
High dose intravenous labetalol for the resection of metastatic pheochromocytoma.
Topics: Adrenal Gland Neoplasms; Antihypertensive Agents; Blood Pressure; Humans; Injections, Intravenous; L | 1996 |
The preoperative management of phaeochromocytoma.
Topics: Adolescent; Adrenal Gland Neoplasms; Adrenergic alpha-Antagonists; Adult; Blood Pressure; Female; Hu | 1998 |
[Use of labetalol in the anesthetic management of pheochromocytoma].
Topics: Adrenal Gland Neoplasms; Adult; Antihypertensive Agents; Carcinoma, Medullary; Humans; Hypertension; | 1999 |
Elevated vascular resistance after labetalol during resection of a pheochromocytoma (brief report).
Topics: Adrenal Gland Neoplasms; Adult; Antihypertensive Agents; Cardiac Output; Humans; Labetalol; Male; Ph | 2002 |
Hypertensive response to labetalol in phaeochromocytoma.
Topics: Adrenal Gland Neoplasms; Blood Pressure; Ethanolamines; Female; Humans; Hypertension; Labetalol; Mid | 1978 |
Hypertensive response to labetalol in phaeochromocytoma.
Topics: Adrenal Gland Neoplasms; Ethanolamines; Humans; Hypertension; Labetalol; Pheochromocytoma; Receptors | 1978 |
Labetalol and urinary metadrenalines.
Topics: Adrenal Gland Neoplasms; Epinephrine; Ethanolamines; Humans; Labetalol; Metanephrine; Normetanephrin | 1979 |
[Pheochromocytoma treated with combined alpha-beta blockader].
Topics: Adrenal Gland Neoplasms; Aged; Ethanolamines; Humans; Labetalol; Male; Pheochromocytoma | 1979 |
Labetalol in the treatment of a patient with phaechromocytoma: a case report.
Topics: Adrenal Gland Neoplasms; Blood Pressure; Child; Ethanolamines; Female; Humans; Hypertension; Injecti | 1979 |
Use of labetalol during hypotensive anaesthesia and in the management of phaeochromocytoma.
Topics: Adolescent; Adrenal Gland Neoplasms; Adult; Anesthesia; Ethanolamines; Female; Heart Rate; Humans; H | 1979 |
Falsely high urinary catecholamines induced by labetalol.
Topics: Adrenal Gland Neoplasms; Adult; Catecholamines; Ethanolamines; False Positive Reactions; Female; Hum | 1979 |
MIBG scintigraphy of a patient with pheochromocytoma on labetalol therapy.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Adult; Humans; Iodine Radioisotopes; Iodobenzenes; L | 1992 |
HPLC of urinary catecholamines in the presence of labetalol, captopril, and alpha-methyldopa.
Topics: Adrenal Gland Neoplasms; Captopril; Catecholamines; Chromatography, High Pressure Liquid; False Posi | 1990 |
Labetalol reduces iodine-131 MIBG uptake by pheochromocytoma and normal tissues.
Topics: 3-Iodobenzylguanidine; Adolescent; Adrenal Gland Neoplasms; Adult; Aged; Aged, 80 and over; Drug Int | 1989 |
Non-resectable phaeochromocytoma: long term follow-up.
Topics: Adrenal Gland Neoplasms; Adult; Antineoplastic Combined Chemotherapy Protocols; Aortography; Female; | 1989 |
Phaeochromocytoma as a cause of pulmonary oedema.
Topics: Adrenal Gland Neoplasms; Adult; Humans; Labetalol; Male; Pheochromocytoma; Pulmonary Edema | 1987 |
[Pheochromocytoma and myocardial infarction (apropos of a case in a 34-year-old man)].
Topics: Adrenal Gland Neoplasms; Adult; Humans; Hypertension; Labetalol; Male; Myocardial Infarction; Pheoch | 1986 |
Use of atracurium and labetalol in a patient with phaeochromocytoma.
Topics: Adrenal Gland Neoplasms; Adult; Atracurium; Female; Humans; Hypertension; Intraoperative Complicatio | 1986 |
Rapid cyclic fluctuations of blood pressure associated with treatment of pheochromocytoma by labetalol.
Topics: Administration, Oral; Adrenal Gland Neoplasms; Blood Pressure; Humans; Labetalol; Male; Middle Aged; | 1985 |
Erroneous diagnosis of phaeochromocytoma in hypertensive patient on labetalol.
Topics: Adrenal Gland Neoplasms; Diagnostic Errors; Ethanolamines; Humans; Hypertension; Labetalol; Male; Mi | 1985 |